The failure of implant therapy is characterized by the presence of visual signs of inflammation and bleeding on probing, mucositis (PIM) and in cases of peri-implantitis (PI), loss of supporting bone, caused by ineffective maintenance management.
Among the risk indicators for the health of the tissues of the patient wearing an implant prosthesis, the control of bacterial biofilm is certainly a priority, and therefore the effective management of the assisted person's home hygiene lifestyle and follow-ups for therapy sessions non-surgical periodontal treatment, important aspects for the success of implant therapy must be considered.
The advantages of a digital platform for one-to-one communication must be taken into consideration, allowing a new language of care through technology, and effective, shared and controlled personalization of follow-ups.
The prosthetic superstructure of the implant often prevents effective home hygiene around the implant neck and conventional mechanical therapies adopted in the treatment of periodontal disease have their limitations so obtaining good access to the affected area can be difficult, which is why technology offers problem solving by facilitating the operator and assisted person. The choice of the same and of innovative clinical approaches must consider the importance of the scientific support that ensures the quality of the result of the therapy.
PIID in oral surgery can develop in the early postoperative period due to impaired wound healing (early infection) or after the implant integration process (late infection) a significant cause of more frequent dental implant failure. The innovative clinical approaches of ozone therapy and photodynamics must be perceived as a considerable support for the success of implant maintenance.
For home oral hygiene therapy, photodynamic therapy allows you to have control over bacterial activity and/or inflammation with easy applications.
Before application, the patient must dissolve one Lumorinse tablet and rinse for 60 seconds.
Subsequently you can insert the Lumoral and activate the photo-activation. Individual risk factors must be considered for the frequency of home use, which in case of use on a patient for preventive purposes, will be used by the patient 2 times a week for 10 minutes, in case of mucositis 1 time a day for 10 minutes, and in case of peri-implantitis 2 times a day for 4 weeks with 30 minute photo-activation.
Finnish researchers from the University of Helsinki, Department of Oral and Maxillofacial Pathology, and the Department of Dental Medicine of the Karolinska Institutet, have demonstrated how home photodynamics can improve the state of health of the tissues adjacent to the implant.
Ozone therapy with ozonated olive oil is another clinical approach that offers the possibility of more effective management of eubiosis conditions in the oral cavity of assisted people who have undergone implant therapy.
Precisely due to the difficulties of access that often make it difficult to control bacterial biofim, the use of mouthwash becomes essential, and among the new protocol scenarios, the use of ozonated olive oil mouthwash, thanks to its antiseptic, anti-inflammatory capacity anti-edema, anesthetic and healing, and a home instrument which is also not aggressive, respects the microbiological balance of the oral cavity, is not alcoholic and does not create discolouration on the dental and prosthetic-implant surfaces.
In case of treatment for peri-implantitis, it will be possible, after non-surgical periodontal therapy, to insert the extra-ozonated olive oil Perioral3 (Gemavip) into the peri-implant pocket, and for home hygiene, use the Ialozon home gel on the inflamed implant site , which can be used with toothbrush and pipe cleaner.
The difficult management of oral health is entrusted to the expertise of the dental hygienist, who must be open to new clinical approaches with the aim of better results in maintenance therapy.
Pediatric dentistry 10 February 2026
Pediatric Dentists' Approaches to Dental Treatment of Children with Dental Fear and Anxiety
Dental fear and anxiety (DFA) are important facets of pediatric dental treatment and may cause oral health neglect and dental treatment evasion.
Oral surgery 14 February 2021
Authors:Magda Mensi, Elisabetta Audino, Eleonora Scotti, Emanuele Zanola, Elisa Bettinsoli, Stefano Negrini, Luca Visconti, Stefano Alessandro Salgarello
INTRODUCTIONThe aim of this retrospective observational study is the comparison between two different surgical approaches for the ONJ treatment in terms of healing and absence of recurrences. These...
Oral surgery 10 April 2026
A systematic literature search in MEDLINE, Embase, and the Guideline websites, from October 2007 to October 2012, produced articles that were critically evaluated.
News 23 March 2026
New Gingividual® Concept Basic supports standardised digital workflows for soft tissue management
Camlog announces the international launch of Gingividual® Concept Basic, a standardised, digital-first solution designed to streamline implant prosthetic workflows and support predictable soft...
Implantology 24 December 2025
Soft tissue management in aesthetic implantology: clinical case with 15-year follow-up
Implant therapy is widely recognized as an effective and predictable solution for replacing missing teeth, supported by extensive scientific evidence.
Prosthodontics 16 April 2026
The use of orthodontics before fixed prosthodontics in restorative dentistry
For a variety of reasons, orthodontic intervention is often overlooked as a viable modality to correct occlusal, axial, rotational, and space discrepancies before undertaking fixed prosthetic...
Editorials 16 April 2026
Congratulations to Ane Poly, D.D.S., M.Sc., Ph.D., a clinical assistant professor in the UF Department of Endodontics, who was recently chosen as the college’s representative to the Council of...
ONEDAYBIOTECH products garner honor as one of the 16th Annual Readers’ Choice Top 25 Implant Products
News 16 April 2026
National leader in oral health integration and equity joins CareQuest Institute executive team.
News 16 April 2026
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...